These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 14755323)
21. Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study. Oehler-Jänne C; Taverna C; Stanek N; Negretti L; Lütolf UM; Ciernik IF Hematol Oncol; 2008 Jun; 26(2):82-90. PubMed ID: 18085574 [TBL] [Abstract][Full Text] [Related]
22. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease. Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918 [TBL] [Abstract][Full Text] [Related]
23. Modified Magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. Pereira J; Bellesso M; Pracchia LF; Neto AE; Beitler B; de Almeida Macedo MC; Dias LC; Dorlhiac-Llacer PE; Dulley FL; Chamone D Leuk Res; 2006 Jun; 30(6):681-5. PubMed ID: 16288806 [TBL] [Abstract][Full Text] [Related]
24. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature. Tsukasaki K; Maeda T; Arimura K; Taguchi J; Fukushima T; Miyazaki Y; Moriuchi Y; Kuriyama K; Yamada Y; Tomonaga M Bone Marrow Transplant; 1999 Jan; 23(1):87-9. PubMed ID: 10037056 [TBL] [Abstract][Full Text] [Related]
25. Successful outcome of patients with relapsed/refractor Hodgkin lymphoma treated with high dose chemotherapy at the National Adult Bone Marrow Transplant Unit at St. James's Hospital. Bacon CL; Daly P; Sheane B; Conneally EC; Browne PV; McCann S; Ni Chongaile M; O'Brian DS; Mc Dermott R; Hollywood D; Wilson L; Vandenberghe E Ir Med J; 2009 Jan; 102(1):26-8. PubMed ID: 19284016 [TBL] [Abstract][Full Text] [Related]
26. Autologous stem-cell transplantation in patients with HIV-related lymphoma. Balsalobre P; Díez-Martín JL; Re A; Michieli M; Ribera JM; Canals C; Rosselet A; Conde E; Varela R; Cwynarski K; Gabriel I; Genet P; Guillerm G; Allione B; Ferrant A; Biron P; Espigado I; Serrano D; Sureda A J Clin Oncol; 2009 May; 27(13):2192-8. PubMed ID: 19332732 [TBL] [Abstract][Full Text] [Related]
27. Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma. Sohn BS; Park I; Kim EK; Yoon DH; Lee SS; Kang BW; Jang G; Choi YH; Kim C; Lee DH; Kim S; Huh J; Suh C Bone Marrow Transplant; 2009 Sep; 44(5):287-93. PubMed ID: 19234508 [TBL] [Abstract][Full Text] [Related]
29. High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation. Bug G; Atta J; Klein SA; Hertenstein B; Bergmann L; Boehrer S; Mousset S; Hoelzer D; Martin H Ann Hematol; 2005 Oct; 84(11):748-54. PubMed ID: 16001243 [TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875 [TBL] [Abstract][Full Text] [Related]
31. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas]. Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047 [TBL] [Abstract][Full Text] [Related]
32. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy. Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208 [TBL] [Abstract][Full Text] [Related]
33. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients. Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808 [TBL] [Abstract][Full Text] [Related]
34. [Treatment outcomes and prognostic analyses of relapsed or refractory T-cell non-Hodgkin's lymphoma]. Gao Y; Huang HQ; Lin XB; Cai QQ; Pan ZH; Wang BF; Bu Q Ai Zheng; 2007 Aug; 26(8):909-13. PubMed ID: 17697558 [TBL] [Abstract][Full Text] [Related]
35. Autologous or allogeneic transplantation in B- and T-cell lymphomas. Schmitz N; Nickelsen M; Glaß B Best Pract Res Clin Haematol; 2012 Mar; 25(1):61-73. PubMed ID: 22409824 [TBL] [Abstract][Full Text] [Related]